BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2014 3:52:00 PM | Browse: 1072 | Download: 947
 |
Received |
|
2013-07-24 11:19 |
 |
Peer-Review Started |
|
2013-07-24 14:01 |
 |
To Make the First Decision |
|
2013-09-27 16:49 |
 |
Return for Revision |
|
2013-09-29 17:09 |
 |
Revised |
|
2013-09-30 22:45 |
 |
Second Decision |
|
2013-11-29 11:09 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-11-30 01:22 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-01-06 11:22 |
 |
Publish the Manuscript Online |
|
2014-01-19 14:17 |
Category |
Virology |
Manuscript Type |
Topic Highlights |
Article Title |
Is hepatitis B-virucidal validation of biocides possible with the use of surrogates?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Andreas Sauerbrei |
Funding Agency and Grant Number |
|
Corresponding Author |
Dr. Andreas Sauerbrei, Professor, Institute of Virology and Antiviral Chemotherapy, Jena University Clinic, Friedrich Schiller University of Jena, Hans-Knoell-Straße 2, D-07745 Jena, Germany. andreas.sauerbrei@med.uni-jena.de
|
Key Words |
Hepatitis B virus; Surrogate model; Duck hepatitis B virus; Disinfectants; Testing virucidal efficacy |
Core Tip |
There is a need for disinfectants with proven virucidal activity against the hepatitis B virus (HBV). Feasible HBV infectivity assays are not available; therefore, the establishment of surrogate models for HBV infection is of high importance. This paper reviews the application of the most promising and feasible assay, the use of the duck hepatitis B virus, which can be propagated in vitro in primary duck embryonic hepatocytes. The paper also describes how and why this model can be used to evaluate the efficacy of disinfectants against HBV.
|
Publish Date |
2014-01-19 14:17 |
Citation |
Sauerbrei A. Is hepatitis B-virucidal validation of biocides possible with the use of surrogates? World J Gastroenterol 2014; 20(2): 436-444 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i2/436.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i2.436 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345